Table 4. Clinicopathological variables and the expression status of CLCA4 and MS4A12.

		CLCA4		P	MS4A12		P
		Low (%)	High (%)		Low (%)	High (%)
Sex
Male	161	77(40.1%)	84(43.8%)	0.007*	73(38.0%)	88(45.8%)	0.001*
Female	31	23(12.0%)	8(4.2%)		24(12.5%)	7(3.6%)
Age
<65 years	88	44(22.9%)	44(22.9%)	0.595	38(19.8%)	50(26.0%)	0.061
≥65 years	104	56(29.2%)	48(25.0%)		59(30.7%)	45(23.4%)
Overall survival
<60 months	122	90(46.9%)	32(16.7%)	<0.001*	81(42.2%)	41(21.4%)	<0.001*
≥60 months	70	10(5.2%)	60(31.3%)		16(8.3%)	54(28.1%)

Pearson’s chi-squared test was used.

^*P<0.05